Psychological dysfunction and HIV/AIDS risk behavior

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 2, 1996, Pages 198-202

  Camacho, L Mabel ^a   Brown, Barry S ^a   Simpson, D Dwayne ^a  

^a TEXAS CHRISTIAN UNIVERSITY   (United States)

Author keywords

Drug treatment; HIV risk; Psychological problems

Indexed keywords

COCAINE; DIAMORPHINE; METHADONE; OPIATE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANXIETY; ARTICLE; DEPRESSION; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; FEMALE; HIGH RISK POPULATION; HOSTILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; METHADONE TREATMENT; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; RATING SCALE; SEXUAL BEHAVIOR;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0030071875     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199602010-00012     Document Type: Article

References (31)

1. Centers for Disease Control and Prevention. Trends, U.S. AIDS cases. HIV/AIDS Prev 1994;5:4.
2. Abdul-Quadar AS, Friedman SR, Des Jarlais D, Marmor MM, Maslansky R, Bartelme S. Methadone maintenance and behavior by intravenous drug users that can transmit HIV. Contemp Drug Prob 1987;Fall:425-34.
3. Ball JC, Lange WR, Myers CP, Friedman SR. Reducing the risk of AIDS through methadone maintenance treatment. J Health Soc Behav 1988;29:214-26.
4. Hubbard RL, Marsden ME, Rachal JV, Harwood HJ, Cavanaugh ER, Ginzburg HM. Drug abuse treatment: A national study of effectiveness. Chapel Hill, North Carolina: University of North Carolina Press, 1989.
5. Brown BS, Beschner GM. AIDS and HIV infection-implications for drug abuse treatment. J Drug Issues 1989; 19:141-62.
6. Rounsaville BJ, Tierney T, Crits-Cristoph K, Weissman MM, Klebler HD. Predictors of outcome in treatment of opiate addicts: evidence for the multidimensional nature of addicts' problems. Compr Psychiatry 1982;23:462-78.
7. Joe GW, Knezek L, Watson D, Simpson DD. Depression and decision-making among intravenous drug users. Psychol Rep 1991;68:339-47.
8. Simpson DD, Knight K, Ray S. Psychosocial and cognitive correlates of AIDS - risky behaviors. AIDS Education Prev 1993;5:121-30.
9. Metzger DS, Woody GE, Druley P. Psychiatric symptoms, high risk behaviors, and HIV positivity among methadone patients. In: Harris L, ed. Problems of drug dependence 1990: Proceedings of the 52nd Annual Scientific Meeting. The Committee on Problems of Drug Dependence (NIDA Research Monograph 105, DHHS Publication No. ADM 91-1753). Rockville, Maryland: National Institute on Drug Abuse, 1991:491-1.
10. Abbott PJ, Weller SB, Walker MD. Psychiatric disorders of opioid addicts entering treatment: preliminary data. J Abnorm Dis 1994;13:1-11.
11. Malow RM, Corrigan SA, Pena JM, Calkins AM, Bannister TM. Mood and HIV risk behavior among drug-dependent veterans. Psychol Addict Behav 1992;6:131-4.
12. Chaisson RE, Bacchelli P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989;261:561-5.
13. Des Jarlais DC, Friedman SR. Intravenous cocaine, crack, and HIV infection. JAMA 1988;259:1945-6.
14. Iguchi MY, Platt JJ, French J, et al. Correlates of HIV se-ropositivity among injection drug users not in treatment. J Drug Issues 1992;22:849-66.
15. Larrat EP, Zierler S. Entangled epidemics: cocaine use and HIV disease. J Psychoactive Drugs 1993;25:207-21.
16. Schoenbaum EE, Hartel D, Sclwyn PA, Klein RS, Davenny K, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med 1989;321: 874-9.
17. Dolan MP, Black JL, Malow RM, Penk WE. Clinical differences among cocaine, opioid, and speedball users in treatment. Psychol Addict Behav 1991;5:78-84.
18. Simpson DD, Chatham LR, Joe GW. Cognitive enhancements to treatment in DATAR: Drug Abuse Treatment for AIDS Risks Reduction. In: Inciardi J, Tims F, Fletcher B, eds. Innovative approaches to the treatment of drug abuse: Volume 1 - program models and strategies. Westport, Connecticut: Greenwood Press, 1993:161-77.
19. Simpson DD. TCU/DATAR forms manual: Drug Abuse Treatment for AIDS-Risks Reduction (DATAR). Fort Worth: Texas Christian University, Institute of Behavioral Research, 1992.
20. Knight K, Holcom M, Simpson DD. TCU psychosocial functioning and motivation scales: manual on psychometric properties. Forth Worth: Texas Christian University, Institute of Behavioral Research, 1994.
21. Joe GW, Simpson DD. HIV risks, gender, and cocaine use among opiate users. Drug Alcohol Depend 1995;37:23-8.
22. Booth RE. Predictors of unsafe needle practices: injection drug users in Denver. J Acq Immune Def Synd 1994;7:504-8.
23. Raymond CA. Study of IV drug users and AIDS finds differing infection rate risk behaviors. JAMA 1988;260:3105.
24. Texas Department of Health. Texas AIDS Cases: Surveillance Report. 1995, Jan. 4.
25. Rounsaville BJ, Kleber HD. Psychotherapy/counseling for opiate addicts: strategies for use in different settings. Int J Addict 1985;20:869-96.
26. Bergman HC, Harris M. Substance abuse among, young adult chronic patients. Psychosoc Rehab J 1985;9:49-54.
27. Regier DA, Shapiro S, Kessler LG, Taube CA. Epidemiology and health service resource allocation policy for alcohol, drug abuse, and mental disorders. Public Health Rep 1984; 99:483-92.
28. Butynski W, Canova D. State resources and services related to alcohol and drug abuse problems, fiscal year 1987. Washington, DC: National Association of State Alcohol and Drug Abuse Directors, 1988.
29. McLellan AT, Woody GE, Luborsky L, O'Brien CP, Druley KA. Predicting response to alcohol and drug abuse treatments: role of psychiatric severity. Arch Gen Psychiatry 1983;40:620-5.
30. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5 year follow-up of cocaine use among treated opioid addicts. Arch Gen Psychiatry 1987;44:281-4.
31. Hubbard RL, Marsden ME. Relapse to use of heroin, cocaine, and other drugs in the first year after treatment. In: Tims FM, Leukefeld CG, eds. Relapse and recovery in drug abuse (NIDA Research Monograph 72, DHHS Publication No. ADM 86-M73). Rockville, MD: NIDA, 1986;157-66.